DiaMedica Therapeutics
DMAC
DMAC
26 hedge funds and large institutions have $3.14M invested in DiaMedica Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
58% less capital invested
Capital invested by funds: $7.42M → $3.14M (-$4.28M)
Holders
26
Holding in Top 10
–
Calls
$10K
Puts
$11K
Top Buyers
| 1 | +$55.1K | |
| 2 | +$26.4K | |
| 3 | +$16.3K | |
| 4 |
Jane Street
New York
|
+$15.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.8K |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$30K | |
| 3 | -$24K | |
| 4 |
SC
Shay Capital
New York
|
-$20K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$17.9K |